US_FEDERAL process · buyer country US · award
PURIFICATION OF CULTURED HYBRIDOMA IS REQUIRED TO OBTAIN PRECLINICAL DATA TRANSLATING NCI VACCINE BRANCH INVENTION TO CLINICAL TRIALS. THE PROCESS DOES NOT INVOLVE ANY ANIMAL BECAU
Department of Health and Human Services
- Buyer identifier
- Not reported
- Primary supplier
- BIO X CELL, LLC
- Procurement method
- Not reported
- Tender deadline
- Not reported
- Contract period
- Not reported — Not reported
- Native value
- Not reported
- USD comparison
- Not shown — no auditable FX observation
- Official source
- Open notice ↗
Description
PURIFICATION OF CULTURED HYBRIDOMA IS REQUIRED TO OBTAIN PRECLINICAL DATA TRANSLATING NCI VACCINE BRANCH INVENTION TO CLINICAL TRIALS. THE PROCESS DOES NOT INVOLVE ANY ANIMAL BECAUSE THE HYBRIDOMA IS ALREADY ESTABLISHED AND IT IS A SIMPLE LABORATORY
Suppliers
- BIO X CELL, LLC · primary
Official lifecycle
Process timeline
- Award announced
PURIFICATION OF CULTURED HYBRIDOMA IS REQUIRED TO OBTAIN PRECLINICAL DATA TRANSLATING NCI VACCINE BRANCH INVENTION TO CLINICAL TRIALS. THE PROCESS DOES NOT INVOLVE ANY ANIMAL BECAU
- Value increased
PURIFICATION OF CULTURED HYBRIDOMA IS REQUIRED TO OBTAIN PRECLINICAL DATA TRANSLATING NCI VACCINE BRANCH INVENTION TO CLINICAL TRIALS. THE PROCESS DOES NOT INVOLVE ANY ANIMAL BECAU
Auditable model output
Predictive intelligence
Append-only source history
Source records
| Record | Date | Stages | Fetched |
|---|